Oral Azacitidine and Lenalidomide Combinations in Myelodysplastic Syndromes

1 Views
administrator
administrator
07/04/23

Harry P. Erba, MD, PhD, summarizes clinical studies presented at the 2013 ASH Annual Meeting focused on the administration of oral azacitidine and combination therapies for patients with myelodysplastic syndromes.

To view more from this discussion, visit http://www.onclive.com/peer-exchange/mds-cml

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next